A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
NCT02016482 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 217
Last updated 2017-05-30
Summary
This study is being conducted to assess the safety and efficacy of adalimumab in participants with nail psoriasis.
Conditions
- Nail Psoriasis
- Plaque Psoriasis
Interventions
- BIOLOGICAL
- OTHER
-
Placebo
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
David Williams, MD · AbbVie
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-10-31
- Completion
- 2016-04-30
More Related Trials
-
Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00645905 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00195676 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00237887 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept
NCT00927069 ·Status: COMPLETED ·Phase: PHASE3
-
A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)
NCT00427362 ·Status: COMPLETED ·Phase: PHASE3
-
Apremilast in Palmo-Plantar Psoriasis
NCT02400749 ·Status: COMPLETED ·Phase: PHASE4
-
Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis
NCT01722214 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis
NCT00848055 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities
NCT01401452 ·Status: COMPLETED
-
Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
NCT00574249 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China
NCT03236870 ·Status: COMPLETED
-
Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis
NCT03897075 ·Status: COMPLETED ·Phase: PHASE3
-
Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00338754 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet
NCT00312026 ·Status: COMPLETED ·Phase: PHASE4
-
Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis
NCT04999839 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet
NCT00735787 ·Status: COMPLETED ·Phase: PHASE4
-
A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate
NCT01251614 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Adalimumab Therapy on Psoriasis Patient
NCT05889338 ·Status: UNKNOWN ·Phase: NA
-
Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis
NCT00396422 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab
NCT00833729 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis
NCT00604682 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
NCT01690299 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs
NCT01084668 ·Status: COMPLETED
-
An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis
NCT05124080 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment
NCT01316224 ·Status: COMPLETED